
DCVC Announcements
Many diseases have been considered untreatable because there are no known molecules that can interrupt the given underlying biomolecular pathways. Totus uses high-throughput cell-based assays and large-scale machine learning to screen the activity of billions of compounds across the entire human genome, yielding new covalent drugs that can irreversibly bind to disease-causing proteins and silence them.
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Programming stem cells to differentiate into desired cell types, faster
Using state-of-the-art machine learning models to create custom-build protein drugs
Mapping the brain-body axis to achieve proper immune balance